Department of Internal Medicine, Wayne State University School of Medicine/Detroit Medical Center, Detroit, MI, USA.
Department of Internal Medicine, Englewood Hospital and Medical Center, Seton Hall University-Hackensack Meridian School of Medicine, Englewood, NJ, USA.
Int J Cardiol. 2019 Feb 15;277:16-19. doi: 10.1016/j.ijcard.2018.09.098. Epub 2018 Sep 27.
Multiple studies evaluated the outcomes and complications rate of Takotsubo Syndrome (TTS) in patients with and without advanced chronic kidney disease (CKD), revealed conflicting results. This study aims to assess the clinical outcomes and impact of advanced CKD on patients hospitalized with Takotsubo Syndrome. Patients who presented with Takotsubo cardiomyopathy between 2010 and 2014 were identified in the National Inpatient Sample (NIS) database using the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM), and subsequently were divided into two groups, with advanced CKD and without advanced CKD. NIS is the largest all-payer inpatient stays database in the United States. The primary outcome was the effect of advanced CKD on inpatient mortality in comparison to the non-advanced CKD group. Secondary outcomes were the impact of CKD on TTS in-hospital complications. We also evaluated the length of hospital stay and the cost of hospitalization. Propensity score-matched analysis was performed to address potential confounding. The advanced CKD group had no significant increase in the risk of In-hospital mortality (OR 0.99; 95% CI 0.75-1.31, P = 0.269). However, advanced CKD patients were more likely to develop acute kidney injury (AKI) requiring dialysis (OR: 5.12, 95% CI: 3.16-8.30, P = <0.0001), and were more likely to stay longer at the hospital (OR 1.12; 95% CI 1.03 to 1.22, P 0.010). In conclusion, advanced chronic kidney disease does not increase immediate in-hospital mortality, neither most of the TTS in-hospital complications, apart from AKI and hospital length of stay, in comparison to the patients with non-advanced CKD.
多项研究评估了伴有和不伴有晚期慢性肾脏病(CKD)的 Takotsubo 综合征(TTS)患者的结局和并发症发生率,结果存在差异。本研究旨在评估晚期 CKD 对因 Takotsubo 心肌病住院患者的临床结局和影响。在国家住院患者样本(NIS)数据库中,使用国际疾病分类第 9 版临床修订版(ICD-9-CM),于 2010 年至 2014 年期间确定 Takotsubo 心肌病患者,并随后将患者分为两组,一组为晚期 CKD 组,一组为非晚期 CKD 组。NIS 是美国最大的全支付住院患者数据库。主要结局是与非晚期 CKD 组相比,晚期 CKD 对住院死亡率的影响。次要结局是 CKD 对 TTS 院内并发症的影响。我们还评估了住院时间和住院费用。采用倾向评分匹配分析来解决潜在混杂因素。晚期 CKD 组住院死亡率无显著增加(OR 0.99;95%CI 0.75-1.31,P=0.269)。然而,晚期 CKD 患者更有可能发生需要透析的急性肾损伤(AKI)(OR:5.12,95%CI:3.16-8.30,P<0.0001),且更有可能延长住院时间(OR 1.12;95%CI 1.03-1.22,P<0.010)。总之,与非晚期 CKD 患者相比,晚期 CKD 患者的即时院内死亡率没有增加,除 AKI 和住院时间外,大多数 TTS 院内并发症也没有增加。